Edesa Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 687.50 K | $1.70 M | 100.00% | 9.79% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 687.50 K | $1.70 M | 0.00% | 9.79% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 687.50 K | $1.70 M | 0.00% | 9.79% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 625.00 K | $1.54 M | 0.00% | 8.90% |
| VANGUARD GROUP INC | 11/07/2025 | 45.54 K | $111.13 K | 187.08% | 0.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 45.23 K | $110.38 K | 61.80% | 0.64% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/22/2025 | 37.55 K | $93.00 K | 7.27% | 0.53% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 25.00 K | $61.75 K | 100.00% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 14.61 K | $35.65 K | 100.00% | 0.21% |
| CITADEL ADVISORS LLC | 11/14/2025 | 14.03 K | $34.24 K | -40.32% | 0.20% |
| CITIGROUP INC | 11/10/2025 | 2.00 K | $4.88 K | 100.00% | 0.03% |
| UBS GROUP AG | 11/13/2025 | 1.82 K | $4.49 K | 166.33% | 0.03% |
| ROYAL BANK OF CANADA | 11/14/2025 | 1.82 K | $4.00 K | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.28 K | $3.16 K | -45.41% | 0.02% |
| TD WATERHOUSE CANADA INC. | 11/03/2025 | 142 | $362 | 0.00% | 0.00% |
| FIFTH THIRD BANCORP | 11/07/2025 | 100 | $247 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 51 | $126 | -5.56% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 10/21/2025 | 25 | $62 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 6 | $14 | 100.00% | 0.00% |
| DANSKE BANK A/S | 11/19/2025 | 1 | $2 | 100.00% | 0.00% |
| LRI INVESTMENTS, LLC | 11/03/2025 | 1 | $2 | 0.00% | 0.00% |
| DOGWOOD WEALTH MANAGEMENT LLC | 11/12/2025 | 1 | $2 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Edesa Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 27 institutional investors and hedge funds held shares of Edesa Biotech, Inc.. The most heavily invested institutionals were:
Rubric Capital Management LP: 687,500
Stonepine Capital Management, LLC: 687,500
Velan Capital Investment Management LP: 687,500
Nantahala Capital Management, LLC: 625,000
VANGUARD GROUP INC: 45,543
GEODE CAPITAL MANAGEMENT, LLC: 45,234
40.96% of Edesa Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.88 M shares in the last 24 months. This purchase volume represents approximately $7.42 M in transactions.